Positive airway pressure

Global Continuous Positive Airway Pressure Devices Market Forecast to 2027 with COVID-19 Impact and Analysis - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 25, 2020
Medical devices, Health, Medicine, Clinical medicine, Medical specialties, Mechanical ventilation, Positive airway pressure, Continuous positive airway pressure, Non-invasive ventilation, Ventilator, Modes of mechanical ventilation, Continuous spontaneous ventilation

The "Continuous Positive Airway Pressure Devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type; End User; and Geography" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Continuous Positive Airway Pressure Devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type; End User; and Geography" report has been added to ResearchAndMarkets.com's offering.
  • The global continuous positive airway pressure (CPAP) devices market is expected to reach US$ 4,481.41 million by 2027 from US$ 2,462.86 million in 2019.
  • Thus, devices such as CPAP, auto-CPAP, and bi-level positive airway pressure (BiPAP or BPAP) are used as an alternative for ventilator devices.
  • Based on end user, the continuous positive airway pressure (CPAP) devices market has been segmented into emergency health departments and hospitals.

REMSleep Patent Application

Retrieved on: 
Friday, November 20, 2020
Medicine, Clinical medicine, Branches of biology, Sleep disorders, Mechanical ventilation, Continuous positive airway pressure, Medical equipment, Sleep apnea, Positive airway pressure, Obstructive sleep apnea, Apnea, Mandibular advancement splint

Tampa, FL, Nov. 20, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire --REMSleep Holdings, Inc. (OTC PINK: RMSL): REMSleep receives office action from the United States Patent and Trademark Office ("USPTO") concerning the company's patent application 15/595,990 for its Deltawave CPAP nasal pillows device.

Key Points: 
  • Tampa, FL, Nov. 20, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire --REMSleep Holdings, Inc. (OTC PINK: RMSL): REMSleep receives office action from the United States Patent and Trademark Office ("USPTO") concerning the company's patent application 15/595,990 for its Deltawave CPAP nasal pillows device.
  • REMSleep Holdings, Inc. is a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients.
  • With over 30 years of collective experience in CPAP therapy, the REMSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance.
  • REMSleep Holdings, Inc. has a new patent pending, innovative sleep apnea product that will meet multiple market demand and be able to reach and address a large percentage of the patient population who continue to struggle with CPAP compliance.

REMSleep Holdings -- Time Line Update

Retrieved on: 
Thursday, November 19, 2020
Medicine, Clinical medicine, Medical specialties, Mechanical ventilation, Sleep disorders, Continuous positive airway pressure, Medical equipment, Positive airway pressure, Sleep apnea, Obstructive sleep apnea, Apnea, Mandibular advancement splint

Tampa, FL, Nov. 19, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- REMSleep Holdings, Inc. (OTC PINK: RMSL) has initiated bio testing requirements for its flagship Deltawave Nasal Pillow Mask.

Key Points: 
  • Tampa, FL, Nov. 19, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- REMSleep Holdings, Inc. (OTC PINK: RMSL) has initiated bio testing requirements for its flagship Deltawave Nasal Pillow Mask.
  • The new 510K is expected to be completed in time for 1st quarter 2021 market distribution.
  • REMSleep Holdings, Inc. is a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients.
  • With over 30 years of collective experience in CPAP therapy, the REMSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance.

Shareholder Update

Retrieved on: 
Thursday, November 19, 2020
Medicine, Clinical medicine, Branches of biology, Mechanical ventilation, Sleep disorders, Medical equipment, Continuous positive airway pressure, Sleep apnea, Positive airway pressure

TAMPA, FL, Nov. 19, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- REMSleep Holdings, Inc. (OTC PINK: RMSL) Gives an update on FDA process.

Key Points: 
  • TAMPA, FL, Nov. 19, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- REMSleep Holdings, Inc. (OTC PINK: RMSL) Gives an update on FDA process.
  • The new Deltawave nasal pillows mask evolved from the company's original 510K and CPAP mask, Laminair.
  • The company has since exhausted every means possible to a pathway of using the company's original 510K.
  • Our focus is primarily designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions.

Global Sleep Apnea Devices Market Forecast to 2025 - by Type, End-user and Geography - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 10, 2020
Medical devices, Health, Branches of biology, Medicine, Clinical medicine, Sleep disorders, Sleep apnea, Mandibular advancement splint, Apnea, Positive airway pressure, Oral pressure therapy, Sleep, Sleep surgery, Obstructive sleep apnea

Large Pool of Undiagnosed Sleep Apnea Patients is a major factor driving the Sleep Apnea Devices Market during the forecast period 2020-2025.

Key Points: 
  • Large Pool of Undiagnosed Sleep Apnea Patients is a major factor driving the Sleep Apnea Devices Market during the forecast period 2020-2025.
  • Therefore adoption appropriate sleep apnea devices can help to prevent such diseases thereby driving the sleep apnea devices market during the forecast period 2020-2024.
  • Technological innovation in devices for sleep apnea is a major factor driving the Sleep Apnea Devices Market during the forecast period 2020-2025.Sleep Apnea devices include Positive Airway Pressure Therapy, Oral Pressure Therapy, Oral Appliances and Surgery.
  • Furthermore, high cost of sleep apnea treatment disrupts the smooth functioning of the Sleep Apnea Devices Market in 2019.

Asia Pacific Sleep Apnea Devices Market to 2025 - Industry Analysis and Forecast - ResearchAndMarkets.com

Retrieved on: 
Monday, November 9, 2020
Medical devices, Health, Branches of biology, Sleep disorders, Clinical medicine, Medicine, Sleep apnea, Apnea, Sleep, Obstructive sleep apnea, Positive airway pressure

The "Asia Pacific Sleep Apnea Devices Market, by Product Type, by Therapeutic Devices Type, by Diagnostic Devices Type, by Country, Industry Analysis and Forecast, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Asia Pacific Sleep Apnea Devices Market, by Product Type, by Therapeutic Devices Type, by Diagnostic Devices Type, by Country, Industry Analysis and Forecast, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.
  • Keeping an awareness of the adverse effects of untreated sleep apnea, increased use of oral devices and the technical development of sleep apnea machines, significant venture capital funds and a rising number of firms engaged in sleep apnea and oral application are primarily important drivers of the growth market for sleep apnea devices.
  • Increasing awareness about the long-term effects of sleep apnea is expected to drive revenue growth in the forecast period.
  • Based on Therapeutic Devices Type, the market is segmented into PAP Devices, Oral Devices, Nasal Devices and Chin Straps.

Continuous Positive Airway Pressure (CPAP) Device Market to Reach US$ 4 Billion by 2026, Globally |CAGR: 9% | UnivDatos Market Insights

Retrieved on: 
Friday, October 30, 2020
Medicine, Clinical medicine, Medical specialties, Mechanical ventilation, Sleep disorders, Medical equipment, Intensive care medicine, Continuous positive airway pressure, Positive airway pressure, Sleep apnea, Obstructive sleep apnea, Mandibular advancement splint

"Continuous Positive Airway Pressure (CPAP) Device Market is expected to grow at a CAGR of 9% from 2021-2026 to reach US$ 4,151.2 million by 2026.

Key Points: 
  • "Continuous Positive Airway Pressure (CPAP) Device Market is expected to grow at a CAGR of 9% from 2021-2026 to reach US$ 4,151.2 million by 2026.
  • Continuous positive airway pressure therapy (CPAP) uses a device that makes it easier for a person with obstructive sleep apnea (OSA) to breathe during sleep.
  • Global Continuous Positive Airway Pressure (CPAP) Device Market report is studied thoroughly with several aspects that would help stakeholders in making their decisions more curated.
  • Continuous Positive Airway Pressure (CPAP) Device Market Geographical Segmentation Includes:
    North America (the United States, Canada and Rest of North America)
    Based on the estimation, North America dominated the continuous positive airway pressure (CPAP) device market with almost 35% of the market revenue in 2019.

Continuous Positive Airway Pressure (CPAP) Device Market to Reach US$ 4 Billion by 2026, Globally |CAGR: 9% | UnivDatos Market Insights

Retrieved on: 
Friday, October 30, 2020
Medicine, Clinical medicine, Medical specialties, Mechanical ventilation, Sleep disorders, Medical equipment, Intensive care medicine, Continuous positive airway pressure, Positive airway pressure, Sleep apnea, Obstructive sleep apnea, Mandibular advancement splint

"Continuous Positive Airway Pressure (CPAP) Device Market is expected to grow at a CAGR of 9% from 2021-2026 to reach US$ 4,151.2 million by 2026.

Key Points: 
  • "Continuous Positive Airway Pressure (CPAP) Device Market is expected to grow at a CAGR of 9% from 2021-2026 to reach US$ 4,151.2 million by 2026.
  • Continuous positive airway pressure therapy (CPAP) uses a device that makes it easier for a person with obstructive sleep apnea (OSA) to breathe during sleep.
  • Global Continuous Positive Airway Pressure (CPAP) Device Market report is studied thoroughly with several aspects that would help stakeholders in making their decisions more curated.
  • Continuous Positive Airway Pressure (CPAP) Device Market Geographical Segmentation Includes:
    North America (the United States, Canada and Rest of North America)
    Based on the estimation, North America dominated the continuous positive airway pressure (CPAP) device market with almost 35% of the market revenue in 2019.

Positive Airway Pressure Market: CPAP, APAP, BiPAP - Global Growth, Trends, and Forecast 2020-2025 with Koninklijke Philips, ResMed, Smiths Group, 3B Medical, and Apex Medical Dominating - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 21, 2020
Medical devices, Health, Medicine, Clinical medicine, Branches of biology, Sleep disorders, Mechanical ventilation, Medical equipment, RTT, Sleep apnea, Positive airway pressure, Forecast period, PAP, Smiths Group

The "Positive Airway Pressure Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Positive Airway Pressure Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
  • Also, increased awareness of sleep apnea and risk factors such as cardiovascular indications and high blood pressure are expected to fuel the PAP market throughout the forecast period.
  • Still, only 20% of them were diagnosed with the treatment, which drives the market growth in the forecast period.
  • Some of the companies which are currently dominating the market are Koninklijke Philips NV, ResMed Inc., Smiths Group PLC, 3B Medical Inc., and Apex Medical Corp.

keepMED Completes €13 M Series C Financing Round and Advances Towards Regulatory Clearance and Market Launch For keePAP, New Generation Sleep Apnea Device, in Europe and North America

Retrieved on: 
Tuesday, September 29, 2020
Finance, General Health, Health, Consulting, Medical devices, Professional services, Technology, Other Technology, Medicine, Clinical medicine, Sleep disorders, Branches of biology, Obstructive sleep apnea, Sleep apnea, Osa, Positive airway pressure, Obstruction, Airway obstruction, Sleep, Hypopnea, keepMed Ltd. - www.keepap.com, Mérieux Equity Partners - www.merieux-partners.com

Merieux Equity Partners and keepMed announce the completion of a 13 million Series C financing round, attracting a new syndicate of European investors.

Key Points: 
  • Merieux Equity Partners and keepMed announce the completion of a 13 million Series C financing round, attracting a new syndicate of European investors.
  • keepMed has designed and developed keePAP, a unique, responsive and personalized positive airway pressure (PAP) device for treatment of Obstructive Sleep Apnea (OSA).
  • OSA is a disorder characterized by repetitive episodes of upper airway obstruction during sleep, associated with a significantly increased risk of heart disease, diabetes, and stroke.
  • A recent study published in The Lancet Respiratory Medicine1 indicates that nearly one billion adults worldwide have mild to severe OSA.